SymptoLab
PrivateCompany Overview
SymptoLab operates in Healthcare & Life Sciences and is based in New York City, New York. It was founded in 2025.
SymptoLab is a digital health company that provides an AI-powered clinical decision-support platform to help physicians and patients manage complex, hormone-driven conditions.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Healthcare Analytics, Medical AI
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SymptoLab Comparables
Compare SymptoLab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dama Health | 78% | |
| FertilAI | 77% | |
| Syrona Health | 71% |
For institutional investors. Book with your work email.
SymptoLab Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2025
Grew 200% QoQ, from 2 to 6 employees.
For institutional investors. Book with your work email.
SymptoLab Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SymptoLab's valuation, stock price, and market status.
Is SymptoLab a public or private company?
SymptoLab is a private company.
What is the current stock price of SymptoLab?
SymptoLab is a private company, so its shares have no public market price. Caplight tracks SymptoLab's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SymptoLab worth (valuation)?
Valuation information for SymptoLab is not publicly available.
Can I buy SymptoLab stock?
SymptoLab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SymptoLab's last funding round?
Funding round information for SymptoLab is not publicly available.
Who are the main investors in SymptoLab?
Investor information for SymptoLab is not publicly disclosed.
Will SymptoLab IPO soon?
No public IPO plans have been announced for SymptoLab.
How can I track SymptoLab secondary market activity?
Caplight tracks bids, offers, and trades in SymptoLab's shares on secondary markets.